(Q34971424)

English

Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

randomized controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Suhnggwon Kim

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2

object named as

Ho Jun Chin

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Yong-Chul Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ho Suk Koo

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

19 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

e71545

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

19 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Mortality of IgA nephropathy patients: a single center experience over 30 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Corticosteroid therapy in IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Current therapy for IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Predicting the risk for dialysis or death in IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

A new equation to estimate glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Predicting renal outcome in IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

The commonest glomerulonephritis in the world: IgA nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

A tricontinental view of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Antiproteinuric effect of olmesartan in patients with IgA nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Proteinuria in IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of proteinuria improves prognosis in IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course and prognostic factors of clinical early IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0071545

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2013PLoSO...871545K

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34971424&oldid=2045772253"